Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma osmolality regulation refers to the tightly controlled physiological processes that maintain the concentration of solutes relative to water in blood plasma. This homeostasis is essential for normal cellular function because even small deviations can cause significant changes in cell volume—potentially leading to neurological symptoms such as seizures or coma. Key elements include: • Detection by hypothalamic osmoreceptors that sense changes in blood solute concentration.[1][5] • Activation of thirst response and release/inhibition of antidiuretic hormone (vasopressin) from the posterior pituitary gland.[3] • Vasopressin acts on kidney collecting ducts via V2 receptors, increasing aquaporin-mediated water reabsorption when plasma becomes hyperosmolar; conversely, suppression leads to diuresis when hypoosmolarity occurs.[3][4] • The kidneys also regulate sodium handling under hormonal control from aldosterone and angiotensin II—affecting total body fluid volume but secondaryarily influencing osmotic balance.[1] Disorders affecting any component can result in clinically significant disturbances such as hyponatremia/hypernatremia or syndromes like diabetes insipidus/SIADH. In summary, "plasma osmolality regulation" describes an integrated network rather than a discrete druggable target. Its main effectors are vasopressin signaling pathways and renal tubular transporters/channels responsible for fine-tuning body fluid composition.[7]
Stimulation or inhibition of vasopressin receptors alters renal water reabsorption. Diuretics increase urinary excretion of sodium/water. These mechanisms act through the underlying molecular targets within the regulatory system.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma osmolality regulation.